BCDA Stock Price History and Quote Analysis: Insights for Investors
BioCardia, Inc.
Stock Price Today
BioCardia, Inc. (BCDA) stock surged +6.17%, trading at $2.41 on NASDAQ, up from the previous close of $2.27. The stock opened at $2.27, fluctuating between $2.27 and $2.57 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary disease. The company is also developing allogeneic cells therapeutic platform, an investigational culture expanded bone marrow derived mesenchymal cell therapy, which is in Phase I/II trial for the treatment of ischemic systolic heart failure. In addition, it offers the Helix biotherapeutic delivery system that delivers therapeutics into the heart muscle with a penetrating helical needle from within the heart; and Morph deflectable guides and sheaths. The company is based in Sunnyvale, California.
Company Information
| Employees | 16 |
| Beta | 1.255 |
| Sales or Revenue | $477.00K |
| 5Y Sales Change% | -0.846% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
BioCardia, Inc. (NASDAQ: BCDA) stock price is $2.41 in the last trading session. During the trading session, BCDA stock reached the peak price of $2.57 while $2.27 was the lowest point it dropped to. The percentage change in BCDA stock occurred in the recent session was 6.17% while the dollar amount for the price change in BCDA stock was $0.14.
The NASDAQ listed BCDA is part of Biotechnology industry that operates in the broader Healthcare sector. BioCardia, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Peter A. Altman Ph.D.
Chief Executive Officer, Pres & Director
Mr. David McClung
Chief Financial Officer
Mr. Edward M. Gillis
Senior Vice President of Devices
Dr. Sujith Shetty
Chief Medical Officer and Vice President of Clinical & Regulatory
Dr. Ian McNiece Ph.D.
Chief Scientific Officer
BCDA's closing price is 22.96% higher than its 52-week low of $1.96 where as its distance from 52-week high of $23.25 is -89.63%.
Number of BCDA employees currently stands at 16.
Official Website of BCDA is: https://www.biocardia.com
BCDA could be contacted at phone 650 226 0120 and can also be accessed through its website. BCDA operates from 320 Soquel Way, Sunnyvale, CA 94085, United States.
BCDA stock volume for the day was 155.59K shares. The average number of BCDA shares traded daily for last 3 months was 823.88K.
The market value of BCDA currently stands at $8.44M with its latest stock price at $2.41 and 3.5M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com